Role of estrogen/SERMS [selective estrogen receptor modulators] on cardiac fatty acid metabolism (Aim 1- human studies).
Phase of Trial: Phase II
Latest Information Update: 23 Oct 2018
At a glance
- Drugs Estradiol (Primary) ; Progesterone (Primary)
- Indications Menopausal syndrome
- Focus Pharmacodynamics
- 19 Sep 2018 Status changed to discontinued due to atypically high dropout rate.
- 27 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Aug 2011 Planned end date changed from Jun 2011 to Dec 2011 as reported by ClinicalTrials.gov.